| __timestamp | Madrigal Pharmaceuticals, Inc. | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 15746000 | 59644696 |
| Thursday, January 1, 2015 | 13392000 | 79541000 |
| Friday, January 1, 2016 | 9290000 | 98015000 |
| Sunday, January 1, 2017 | 7672000 | 103958000 |
| Monday, January 1, 2018 | 15293000 | 103654000 |
| Tuesday, January 1, 2019 | 22648000 | 128951000 |
| Wednesday, January 1, 2020 | 21864000 | 135799000 |
| Friday, January 1, 2021 | 37318000 | 149883000 |
| Saturday, January 1, 2022 | 48130000 | 220206000 |
| Sunday, January 1, 2023 | 108146000 | 265542000 |
Unleashing insights
In the competitive world of biotechnology, strategic spending on Selling, General, and Administrative (SG&A) expenses can be a key differentiator. Over the past decade, Madrigal Pharmaceuticals, Inc. and Travere Therapeutics, Inc. have demonstrated contrasting approaches. From 2014 to 2023, Travere consistently outspent Madrigal, with SG&A expenses peaking at approximately 266% higher in 2023. This trend highlights Travere's aggressive investment in administrative and sales functions, potentially fueling its market expansion. Meanwhile, Madrigal's SG&A expenses surged by over 580% from 2014 to 2023, indicating a strategic shift towards scaling operations. These spending patterns reflect broader industry trends where companies balance cost management with growth ambitions. As the biotech landscape evolves, understanding these financial strategies offers valuable insights into corporate priorities and market positioning.
Breaking Down SG&A Expenses: argenx SE vs Madrigal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Incyte Corporation or Travere Therapeutics, Inc.
Selling, General, and Administrative Costs: Sarepta Therapeutics, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing SG&A Expenses: Madrigal Pharmaceuticals, Inc. vs Opthea Limited Trends and Insights
Selling, General, and Administrative Costs: Madrigal Pharmaceuticals, Inc. vs Verona Pharma plc
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and Viking Therapeutics, Inc.
Madrigal Pharmaceuticals, Inc. vs Bausch Health Companies Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Madrigal Pharmaceuticals, Inc. and ImmunityBio, Inc.
Madrigal Pharmaceuticals, Inc. or Celldex Therapeutics, Inc.: Who Manages SG&A Costs Better?
Comparing SG&A Expenses: Alkermes plc vs Travere Therapeutics, Inc. Trends and Insights
Iovance Biotherapeutics, Inc. or Travere Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Travere Therapeutics, Inc. and Celldex Therapeutics, Inc.